Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy. [electronic resource]
Producer: 20020610Description: 3851-3 p. digitalISSN:- 0006-4971
- Adult
- Angiogenesis Inhibitors -- adverse effects
- Enzyme Inhibitors -- adverse effects
- Female
- Hematocrit
- Humans
- Indoles -- adverse effects
- Kinetics
- Male
- Middle Aged
- Polycythemia -- diagnosis
- Pyrroles -- adverse effects
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptors, Growth Factor -- antagonists & inhibitors
- Receptors, Vascular Endothelial Growth Factor
- von Hippel-Lindau Disease -- therapy
No physical items for this record
Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.